Thomas Ebeling
Directeur/Bestuurslid bij CULLINAN THERAPEUTICS, INC.
Vermogen: 1 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Thomas Ebeling
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
99
| Public Company | Pharmaceuticals: Major | 99 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.
83
| Subsidiary | Pharmaceuticals: Major | 83 |
63
| Public Company | Pharmaceuticals: Major | 63 |
University of Hamburg
48
| College/University | Other Consumer Services | 48 |
| Public Company | Movies/Entertainment | 42 | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.
36
| Private Company | Investment Managers | 36 |
| Public Company | Pharmaceuticals: Major | 23 | |
| Public Company | Pharmaceuticals: Major | 17 | |
Moonfare GmbH
 Moonfare GmbH Investment ManagersFinance Moonfare GmbH (Moonfare) is an independent private equity firm founded in 2016 by Alexander Argyros, Heinrich von Liechtenstein and Steffen Pauls. The firm is headquartered in Berlin with additional office in Hong Kong.
16
| Holding Company | Investment Managers | 16 |
Galderma Holding SA
 Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Orna Therapeutics, Inc.
 Orna Therapeutics, Inc. BiotechnologyHealth Technology Orna Therapeutics, Inc. is a biotechnology company that designs and delivers fully engineered circular RNA therapeutics to treat diseases. Orna Therapeutics is based in Cambridge, MA, and has subsidiaries in the United States. The company's proprietary platform combines novel technology to create RNA that drives protein expression with validated and unique delivery solutions. Orna has many advantages over traditional approaches, including simplified production, improved formulatability, and superior protein expression. The company was founded by Daniel Anderson, Raffaella Squilloni, Alex Wesselhoeft, and the CEO is Thomas M. Barnes.
7
| Holding Company | Biotechnology | 7 |
SHL Medical AG
 SHL Medical AG Medical SpecialtiesHealth Technology SHL Medical AG engages in the design, development, and manufacture of advanced drug delivery devices, as well as provides final assembly, labeling, and packaging services for pharma and biotech companies. Its products include autoinjectors, pen injectors, inhaler systems, pressure mattress systems, patient lifting slings, medical soft goods. The firm also offers design-to-build and contract manufacturing of products, such as laboratory handling equipment, neurosurgical devices, and industrial equipment. The company was founded by Roger Samuelsson and Martin Jelf in 1989 and is headquartered in Zug, Switzerland.
6
| Holding Company | Medical Specialties | 6 |
Schwandorfer Rohstoff- und Recycling GmbH
 Schwandorfer Rohstoff- und Recycling GmbH Environmental ServicesIndustrial Services Schwandorfer Rohstoff- und Recycling GmbH is a German waste management company founded in 2006. The private company is based in Schwandorf, Germany and engages in the treatment and disposal of non-hazardous waste materials.
4
| Private Company | Environmental Services | 4 |
Novartis Consumer Health, Inc.
 Novartis Consumer Health, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Novartis Consumer Health, Inc. manufactures and supplies pharmaceutical products. The company is based in Lincoln, NE.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
| Subsidiary | Advertising/Marketing Services | 3 | |
Remagine Media Ventures/Germany/
2
| Subsidiary | Investment Managers | 2 |
Heilpflanzenwohl AG
1
| Private Company | 1 | |
ClearVAT AG
 ClearVAT AG Regional BanksFinance ClearVAT AG provides electronic payment services. The private company is based in Berlin, Germany.
1
| Private Company | Regional Banks | 1 |
Sivantos, Inc. (Canada)
 Sivantos, Inc. (Canada) Medical SpecialtiesHealth Technology Sivantos, Inc. manufactures Signia, Siemens and Rexton hearing aids. It also offers complementary accessories, fitting software, smartphone apps and diagnostics workflow solutions. The company is headquartered in Cambridge, Canada.
1
| Subsidiary | Medical Specialties | 1 |
Reemtsma Cigarettenfabriken GmbH
 Reemtsma Cigarettenfabriken GmbH TobaccoConsumer Non-Durables Reemtsma Cigarettenfabriken GmbH engages in the production and sale of tobacco, cigarettes, and e-cigarettes. It distributes its products under the John Player Special, Gauloises, West, Davidoff, Drum, Rizla, Route 66, Peter Stuyvesant, R1, P&S, and Cabinet brands. The company was founded by Johann Bernhard Reemtsma in 1910 and is headquartered in Hamburg, Germany.
1
| Subsidiary | Tobacco | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thomas Ebeling via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Bioimpact Capital LLC
 Bioimpact Capital LLC Investment ManagersFinance MPM BioImpact LLC (MPM BioImpact) is a venture capital firm a subsidiary of MPM Bioimpact Inc founded in 1996. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Director of Finance/CFO Private Equity Investor Private Equity Investor Consultant / Advisor Private Equity Investor Private Equity Investor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
Nextpoint Therapeutics, Inc.
 Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chairman Director/Board Member Chairman Director/Board Member Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Founder Director/Board Member Director/Board Member Founder | |
| ALLOVIR, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder Chairman | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer Director of Finance/CFO President Chairman | |
| Universität zu Köln | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Founder Founder Director/Board Member | |
Galderma Pharma SA
 Galderma Pharma SA Pharmaceuticals: MajorHealth Technology Galderma Pharma SA discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. It offers drugs, medical dermatology solutions, and therapeutic skin care products for treating hair, nail, and skin diseases. The company was founded in 1981 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
| ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BERTELSMANN SE & CO. KGAA | Movies/Entertainment | Director/Board Member Sales & Marketing Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| 7 Global Capital GP SARL | Investment Managers | Founder Founder Chief Executive Officer | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Chairman Chief Executive Officer Corporate Officer/Principal | |
TriNetX, LLC
 TriNetX, LLC Medical/Nursing ServicesHealth Services TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Clinical Ink, Inc.
 Clinical Ink, Inc. Internet Software/ServicesTechnology Services Clinical Ink, Inc. provides electronic source solutions for clinical research sites. Its solutions include data management, monitoring, clinical sites and patient centric. The company was founded by Douglas E. Pierce Jr. and Tommy Littlejohn on July 19, 2006 and is headquartered in Winston-Salem, NC. | Internet Software/Services | Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| SIG GROUP AG | Industrial Machinery | Director/Board Member Director/Board Member Director/Board Member | |
| CELGENE | Biotechnology | President Corporate Officer/Principal Director/Board Member | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal President | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer General Counsel | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Director/Board Member | |
Cullinan Pearl Corp.
 Cullinan Pearl Corp. BiotechnologyHealth Technology Part of Otsuka Holdings Co., Ltd., Cullinan Pearl Corp. is a company that develops an orally available tyrosine kinase inhibitor. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. Cullinan Pearl was acquired by Taiho Pharmaceutical Co., Ltd. from Cullinan Oncology, Inc. on June 23, 2022 for $405 million. | Biotechnology | Director/Board Member Chief Executive Officer | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree | |
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Founder | |
| OSS Healthcare, Inc. | Director/Board Member Director/Board Member | ||
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
HENSOLDT Holding Germany GmbH
 HENSOLDT Holding Germany GmbH Aerospace & DefenseElectronic Technology HENSOLDT Holding Germany GmbH engages in the supply and distribution of sensor systems for reconnaissance and surveillance purposes. It offers product and system support, simulation solutions, trainings, and special services. The company was founded in 2017 and is headquartered in Taufkirchen, Germany. | Aerospace & Defense | Chairman Director of Finance/CFO | |
The Partnership for New York City, Inc.
 The Partnership for New York City, Inc. Miscellaneous Commercial ServicesCommercial Services The Partnership for New York City operates as a charitable organization. It is a network of business leaders and corporations working for the economic and cultural betterment of all five boroughs of the city. The firm provides networking opportunities, conducts research, participates in policy making and lobbies government. The company was founded by David Rockefeller in 2002 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of London | College/University | Graduate Degree Doctorate Degree | |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Director/Board Member Founder | |
Cullinan Mica Corp.
 Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder | |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Founder |
Statistieken
Internationaal
| Verenigde Staten | 39 |
| Duitsland | 6 |
| Zwitserland | 4 |
| Luxemburg | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 4 |
| Health Services | 4 |
Operationeel
| Director/Board Member | 591 |
| Corporate Officer/Principal | 250 |
| Chairman | 149 |
| Independent Dir/Board Member | 130 |
| Chief Executive Officer | 103 |
Sterkste connecties
| Insiders | |
|---|---|
| Ansbert Gadicke | 56 |
| Johannes Peter Huth | 49 |
| Luke Evnin | 42 |
| Todd Foley | 38 |
| Richard Sykes | 37 |
| Flemming Ørnskov | 34 |
| Andrew Miller | 31 |
| Werner J. Bauer | 29 |
| Edward Hurwitz | 27 |
| Thomas Smith | 27 |
| Sherilyn McCoy | 26 |
| Andreas von Planta | 24 |
| Marion Helmes | 23 |
| Stephen Webster | 23 |
| Anthony Adam Rosenberg | 23 |
- Beurs
- Insiders
- Thomas Ebeling
- Bedrijfsconnecties